Chemed Co. (NYSE:CHE) Given Average Rating of “Hold” by Brokerages

Shares of Chemed Co. (NYSE:CHE) have received a consensus rating of “Hold” from the five brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $359.33.

Several equities research analysts have issued reports on CHE shares. Zacks Investment Research downgraded shares of Farmers & Merchants Bancorp, Inc. (OH) from a “hold” rating to a “strong sell” rating in a research note on Thursday, May 9th. ValuEngine upgraded shares of YY from a “sell” rating to a “hold” rating in a research note on Friday, June 7th. Finally, Oppenheimer started coverage on shares of Identiv in a research note on Tuesday, April 30th. They set an “outperform” rating and a $7.00 price objective for the company.

In other news, insider Kevin J. Mcnamara sold 6,000 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $331.67, for a total value of $1,990,020.00. Following the completion of the transaction, the insider now directly owns 159,334 shares in the company, valued at $52,846,307.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director George J. Walsh III sold 646 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $326.83, for a total transaction of $211,132.18. Following the completion of the transaction, the director now owns 7,070 shares of the company’s stock, valued at $2,310,688.10. The disclosure for this sale can be found here. 3.96% of the stock is owned by insiders.

Hedge funds have recently made changes to their positions in the company. FDx Advisors Inc. boosted its position in shares of Chemed by 12.7% during the 2nd quarter. FDx Advisors Inc. now owns 3,131 shares of the company’s stock valued at $1,130,000 after purchasing an additional 352 shares in the last quarter. Copeland Capital Management LLC boosted its stake in shares of Chemed by 20.2% in the 2nd quarter. Copeland Capital Management LLC now owns 137,043 shares of the company’s stock valued at $49,451,000 after purchasing an additional 23,048 shares in the last quarter. Machina Capital S.A.S. boosted its stake in shares of Chemed by 500.0% in the 2nd quarter. Machina Capital S.A.S. now owns 600 shares of the company’s stock valued at $217,000 after purchasing an additional 500 shares in the last quarter. NEXT Financial Group Inc boosted its stake in shares of Chemed by 342.2% in the 2nd quarter. NEXT Financial Group Inc now owns 1,309 shares of the company’s stock valued at $472,000 after purchasing an additional 1,013 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its stake in shares of Chemed by 1.4% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 6,482 shares of the company’s stock valued at $2,339,000 after purchasing an additional 91 shares in the last quarter. Institutional investors and hedge funds own 87.49% of the company’s stock.

Shares of NYSE CHE traded down $4.24 during trading hours on Friday, reaching $370.84. The stock had a trading volume of 88,299 shares, compared to its average volume of 97,617. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The firm has a market cap of $5.91 billion, a price-to-earnings ratio of 31.08, a price-to-earnings-growth ratio of 3.31 and a beta of 1.11. The company has a fifty day moving average price of $356.62. Chemed has a 52-week low of $260.03 and a 52-week high of $384.64.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Monday, April 29th. The company reported $2.92 EPS for the quarter, missing analysts’ consensus estimates of $2.96 by ($0.04). The business had revenue of $462.03 million during the quarter, compared to the consensus estimate of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. The business’s quarterly revenue was up 5.2% on a year-over-year basis. During the same period last year, the firm earned $2.72 EPS. As a group, equities research analysts anticipate that Chemed will post 12.65 EPS for the current year.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Article: What is an economic bubble?

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.